Events

Upcoming

Past events

MPP Newsletter – January 2016

One licence for a HCV medicine, two new disease areas, four new board members, $120 million in savings: check out MPP’s January newsletter for an update on top initiatives in Q3/Q4 2015.

Global Innovative Financing for the Next Decade

Greg Perry and Philippe Douste-Blazy in Global Health and Diplomacy Magazine

New agreements for TAF signed with Lupin and Micro Labs

View our sub-licensees section

Ensuring new medicines reach those in most need

Read MPP’s Executive Director, Greg Perry and Head of Policy, Esteban Burrone’s comment published in the latest issue of The Lancet HIV

ARV forcasts presented at IAS 2015

Forecasted demand for current and new ARV medicines in low- and middle-income countries, 2014-2025

UNITAID and MPP publish ARV Snapshot Report

See the report

MPP Newsletter July 2015

Review our progress over the past months: new publications, events & more

 

Progress and Achievements Report

MPP highlights milestones of first 5 years

MPP 2014 Annual Report

Read about the MPP’s 2014 achievements

 

Watch a Video Interview with G. Perry

How to convince big pharma to share intellectual property to improve global health